International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e586-e591 , July 2010

Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality

  • Mariana G. Croda

      Affiliations

    • Department of Infectious Diseases, Emílio Ribas Institute of Infectious Diseases, Sao Paulo, Brazil
    • ,
  • José E. Vidal

      Affiliations

    • Department of Neurology, Emílio Ribas Institute of Infectious Diseases, Sao Paulo, Brazil
    • AIDS Clinic, Hospital das Clinicas, University of Sao Paulo School of Medicine, Rua Frei Caneca 557, 01307-001, Sao Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 38812834; fax: +55 11 31205290.
    • ,
  • Adrián V. Hernández

      Affiliations

    • Health Outcomes and Clinical Epidemiology Section, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
    • ,
  • Tiago Dal Molin

      Affiliations

    • Department of Infectious Diseases, Emílio Ribas Institute of Infectious Diseases, Sao Paulo, Brazil
    • ,
  • Felipe A. Gualberto

      Affiliations

    • Department of Infectious Diseases, Emílio Ribas Institute of Infectious Diseases, Sao Paulo, Brazil
    • ,
  • Augusto C. Penalva de Oliveira

      Affiliations

    • Department of Neurology, Emílio Ribas Institute of Infectious Diseases, Sao Paulo, Brazil
    • Clinical Research Unit in Human Retrovirology, University of Campinas, Sao Paulo, Brazil

Received 13 January 2009 ,Revised 8 July 2009 ,Accepted 13 August 2009.

References 

  1. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, Thi Cam Thoa N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis. 2005;192:2134–2141
  2. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Eng J Med. 2005;351:1741–1751
  3. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002;360:1287–1292
  4. British Medical Research Council . Streptomycin treatment of tuberculous meningitis. Lancet. 1948;1:582–596
  5. Ministério da Saúde do Brasil. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV—2007/2008. Available at: http://www.aids.gov.br (accessed October 2008).
  6. Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimarães MD, Oliveira RC. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop. 2006;39:146–151
  7. Vidal JE, Penalva de Oliveira AC, Fink MC, Pannuti CS. AIDS-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in Sao Paulo, Brazil. Rev Inst Med Trop S Paulo. 2008;50:209–212
  8. Trujillo JR, Jaramillo-Rangel G, Ortega-Martinez M, Penalva de Oliveira AC, Vidal JE, Bryant J, et al. International NeuroAIDS: prospects of HIV-1 associated neurological complications. Cell Res. 2005;15:962–969
  9. Zuger A, Tuberculosis . In:  Scheld WM,  Whitley RJ,  Marra CM editor. Infections of the central nervous system. 3rd ed.. Philadelphia: Lippincott-Raven; 2004;p. 441–460
  10. Laguna F, Adrados M, Ortega A, Gonzales-Lahiz JM. Tuberculosis meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS. 1992;6:1165–1167
  11. Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992;326:668–672
  12. Cecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, Perez M, et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS. 2007;21:373–374
  13. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. Q J Med. 1998;91:743–747
  14. Patel VB, Padayatchi N, Bhigjee AI, Allen J, Bhagwan B, Moodley AA, et al. Multidrug-resistant tuberculosis meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis. 2004;38:851–856
  15. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis. 2005;192:79–88
  16. Braga JU, Barreto AM, Werneck AM, Hijjar MA. Inquérito Epidemiológico da resistência às drogas usadas no tratamento da tuberculose no Brasil, 1995–97—Parte III: principais resultados. Boletim da Campanha Nacional Contra a Tuberculose (Rio de Janeiro). 2003;11:76–81
  17. Castelo Filho A, Kritski AL, Barreto AW, Lemos ACM, Ruffi no Netto A, Guimarães CA, et al. II Consenso Brasileiro de tuberculose: diretrizes brasileiras para tuberculose 2004. J Bras Pneumol. 2004;30(Suppl 1):1–56
  18. Pinto WP, Hadad DJ, Silva Telles MA, Ueki SY, Palaci M, Basile MA, et al. Tuberculosis and drug resistance among patients seen at an AIDS reference center in Sao Paulo, Brazil. Int J Infect Dis. 2001;5:93–100
  19. Rozman LM, Santo AH, Rozman MA. Mycobacterium tuberculosis drug resistance in HIV patients in Baixada Santista, Sao Paulo, Brazil. Cad Saude Publica 2007; 23:1051–9.
  20. Thwaites G, Hien TT. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160–170
  21. Trachtenberg JD, Kambugu AD, McKellar M, Semitala F, Mayanja-Kizza H, Samore MH, et al. The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. Int J Infect Dis. 2007;11:524–530
  22. Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14:1401–1407
  23. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007;357:2441–2450
  24. Vidal JE, Hernandez AV, de Oliveira AC, Dauar RF, Barbosa SP, Focaccia R, et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDs. 2005;19:840–848
  25. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675–1682
  26. Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency virus. Clin Infect Dis. 2003;37(Suppl 4):297–303
  27. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;1:29–33
  28. Klautau GB, Kuschnaroff TM. Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in Sao Paulo – Brazil. Braz J Infect Dis. 2005;6:464–467

PII: S1201-9712(09)00347-6

doi: 10.1016/j.ijid.2009.08.012

International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e586-e591 , July 2010

Article Tools

* Image Usage & Resolution